Patents by Inventor Joseph A. Vanartsdalen

Joseph A. Vanartsdalen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for perparing fondaparinux sodium and intermediates useful in the synthesis thereof
    Patent number: 9255119
    Abstract: Processes for the synthesis of the Factor Xa anticoagulent Fondaparinux, and related compounds are described. Also described are protected pentasaccharide intermediates as well as efficient and scalable processes for the industrial scale production of Fondaparinux sodium by conversion of the protected pentasaccharide intermediates via a sequence of deprotection and sulfonation reactions.
    Type: Grant
    Filed: April 18, 2014
    Date of Patent: February 9, 2016
    Assignee: RELIABLE BIOPHARMACEUTICAL CORPORATION
    Inventors: Sourena Nadji, James T. Smoot, Joseph A. Vanartsdalen
  • PROCESS FOR PERPARING FONDAPARINUX SODIUM AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF
    Publication number: 20150018537
    Abstract: Processes for the synthesis of the Factor Xa anticoagulent Fondaparinux, and related compounds are described. Also described are protected pentasaccharide intermediates as well as efficient and scalable processes for the industrial scale production of Fondaparinux sodium by conversion of the protected pentasaccharide intermediates via a sequence of deprotection and sulfonation reactions.
    Type: Application
    Filed: April 18, 2014
    Publication date: January 15, 2015
    Applicant: Reliable Biopharmaceutical Corporation
    Inventors: Sourena NADJI, James T. Smoot, Joseph A. Vanartsdalen
  • Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
    Patent number: 8703923
    Abstract: Processes for the synthesis of the Factor Xa anticoagulent Fondaparinux, and related compounds are described. Also described are protected pentasaccharide intermediates as well as efficient and scalable processes for the industrial scale production of Fondaparinux sodium by conversion of the protected pentasaccharide intermediates via a sequence of deprotection and sulfonation reactions.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: April 22, 2014
    Assignee: Reliable Biopharmaceutical Corporation
    Inventors: Sourena Nadji, James T. Smoot, Joseph A. Vanartsdalen
  • PROCESS FOR PERPARING FONDAPARINUX SODIUM AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF
    Publication number: 20130102764
    Abstract: Processes for the synthesis of the Factor Xa anticoagulent Fondaparinux, and related compounds are described. Also described are protected pentasaccharide intermediates as well as efficient and scalable processes for the industrial scale production of Fondaparinux sodium by conversion of the protected pentasaccharide intermediates via a sequence of deprotection and sulfonation reactions.
    Type: Application
    Filed: September 14, 2012
    Publication date: April 25, 2013
    Applicant: Reliable Biopharmaceutical Corporation
    Inventors: Sourena NADJI, James T. Smoot, Joseph A. Vanartsdalen
  • Process for preparing Fondaparinux sodium and intermediates useful in the synthesis thereof
    Patent number: 8288515
    Abstract: Processes for the synthesis of the Factor Xa anticoagulent Fondaparinux, and related compounds are described. Also described are protected pentasaccharide intermediates as well as efficient and scalable processes for the industrial scale production of Fondaparinux sodium by conversion of the protected pentasaccharide intermediates via a sequence of deprotection and sulfonation reactions.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: October 16, 2012
    Assignee: Reliable Biopharmaceutical Corporation
    Inventors: Sourena Nadji, James T. Smoot, Joseph A. Vanartsdalen
  • PROCESS FOR PREPARING FONDAPARINUX SODIUM AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF
    Publication number: 20110105418
    Abstract: Processes for the synthesis of the Factor Xa anticoagulent Fondaparinux, and related compounds are described. Also described are protected pentasaccharide intermediates as well as efficient and scalable processes for the industrial scale production of Fondaparinux sodium by conversion of the protected pentasaccharide intermediates via a sequence of deprotection and sulfonation reactions.
    Type: Application
    Filed: July 30, 2010
    Publication date: May 5, 2011
    Applicant: Reliable Biopharmaceutical Corporation
    Inventors: Sourena Nadji, James T. Smoot, Joseph A. Vanartsdalen